Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors
- Michael A. Mederos
- , Colin M. Court
- , Benjamin J. Dipardo
- , Joseph R. Pisegna
- , David W. Dawson
- , O. Joe Hines
- , Timothy R. Donahue
- , Thomas G. Graeber
- , Mark D. Girgis
- , James S. Tomlinson
Research output: Contribution to journal › Article › peer-review